Journal of Society of Preventive Korean Medicine (대한예방한의학회지)

Society of Preventive Korean Medicine (대한예방한의학회)
권호 표지

A review study of treatment effects for vascular dementia

혈관성 치매 치료 약물에 대한 문헌 고찰 연구 : 외국문헌을 중심으로

  • Lee, Young-Joon (Department of Preventive Medicine, College of Oriental Medicine, Daeggu Haany University) ;
  • Han, Chang-Hyun (TKM Information Research Division, Korea Institute of Oriental Medicine) ;
  • Jeon, Won-Kyung (TKM Integrated Research Division, Korea Institute of Oriental Medicine) ;
  • Baek, Kyung-Min (Department of Neurology, College of Oriental Medicine, Daeggu Haany University) ;
  • Cheon, Woo-Hyun (Department of internal medicine, College of Oriental Medicine, Daeggu Haany University) ;
  • Choi, Seong-Hun (Department of Anatomy and Histology, College of Oriental Medicine, Daeggu Haany University)
  • 이영준 (대구한의대학교 한의과대학 예방의학교실) ;
  • 한창현 (한국한의학연구원 전통의학정보연구본부) ;
  • 전원경 (한국한의학연구원 한의융합연구본부) ;
  • 백경민 (대구한의대학교 한의과대학 심계내과) ;
  • 전우현 (대구한의대학교 한의과대학 신경과) ;
  • 최성훈 (대구한의대학교 한의과대학 해부학교실)
  • Received : 2011.08.01
  • Accepted : 2011.08.22
  • Published : 2011.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

The average human life span has increased due to the development of modern medicine and science, resulting in prolonged life expectancy and increase in the population counts of the geriatric age group. In particular, a dramatic increase of elderly patients suffering from senile disorders including neurodegenerative diseases, Alzheimer's disease(AD), and vascular dementia has become a serious social problem in public health. Thus, this study is aimed to summarize available clinical trial data on several commonly used medicines include donepezil, rivastigmine, galantamine, memantine and oriental medicine, and examine the effect of oriental medicine combined with western medicine in the treatment of patients with senile disorders using the data from literature reviews and survey studies.

Keywords

References

  1. 이재홍, 혈관성치매의 치료. 대한신경과학회지. 2003 ; 21(5) : 445-454.
  2. 김용원, 고령자 고용촉진방안에 관한 연구 :대구경북지역을 중심으로. 한국경제통상학회. 2008 ; 26(2) : 107-137.
  3. 한국치매협회. http://www.silverweb.or.kr/ test/html/m1_03.asp
  4. 헬스코리아뉴스. 한국인, 혈관성 및 혼합성 치매 비율 높아. 2010.10.25 Available URL ; http://www.hkn24.com/news/articleView. html?idxno=58417
  5. 통계청. 연령별 사망원인. 2009
  6. Black S, Román GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R ; Donepezil 307 Vascular Dementia Study Group. Efficacy and tolerability of donepezil in vascular dementia : positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke. 2003 ; 34(10) : 2323- 2330. https://doi.org/10.1161/01.STR.0000091396.95360.E1
  7. Roman GC, Wilkinson DG, Doody RS, Black SE, Salloway SP, Schindler RJ. Donepezil in vascular dementia : combined analysis of two large-scale clinical trials. Dement Geriatr Cogn Disord. 2005 ; 20(6) : 338-344. https://doi.org/10.1159/000088494
  8. Paci C, Gobbato R, Carboni T, Sanguigni S, Santone A, Curatola L. P300 auditory event-related potentials and neuropsychological study during donepezil treatment in vascular dementia. Neurol Sci. 2006 ; 26(6) : 435-437. https://doi.org/10.1007/s10072-006-0528-8
  9. Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, Pratt RD ; Donepezil 308 Study Group. Donepezil in vascular dementia : a randomized, placebocontrolled study. Neurology. 2003 ; 61(4) : 479-486. https://doi.org/10.1212/01.WNL.0000078943.50032.FC
  10. Ballard C, Sauter M, Scheltens P, He Y, Barkhof F, van Straaten EC, van der Flier WM, Hsu C, Wu S, Lane R. Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia : the VantagE study. Curr Med Res Opin. 2008 ; 24(9) : 2561-2574. https://doi.org/10.1185/03007990802328142
  11. Moretti R, Torre P, Antonello RM, Cazzato G, Bava A. Rivastigmine in subcortical vascular dementia : an open 22-month study. J Neurol Sci. 2002 ; 203-204 : 141-146.
  12. Moretti R, Torre P, Antonello RM, Cazzato G, Bava A. Rivastigmine in subcortical vascular dementia : a randomized, controlled, open 12-month study in 208 patients. Am J Alzheimers Dis Other Demen. 2003 ; 18(5) : 265-272. https://doi.org/10.1177/153331750301800508
  13. Moretti R, Torre P, Antonello RM, Cazzato G, Griggio S, Ukmar M, Bava A. Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia : an open, 16-month, comparative study. Int J Clin Pract. 2004 ; 58(4) : 346-353. https://doi.org/10.1111/j.1368-5031.2004.00127.x
  14. Orgogozo JM, Rigaud AS, Stöffler A, Möbius HJ, Forette F. Efficacy and safety of memantine in patients with mild to moderate vascular dementia : a randomized, placebo-controlled trial(MMM 300). Stroke. 2002 ; 33(7) : 1834-1839. https://doi.org/10.1161/01.STR.0000020094.08790.49
  15. Auchus AP, Brashear HR, Salloway S, Korczyn AD, De Deyn PP, Gassmann- Mayer C ; GAL-INT-26 Study Group. Galantamine treatment of vascular dementia : a randomized trial. Neurology. 2007 ; 69(5) : 448-458. https://doi.org/10.1212/01.wnl.0000266625.31615.f6
  16. Thavichachart N, Phanthumchinda K, Chankrachang S, Praditsuwan R, Nidhinandana S, Senanarong V, Poungvarin N. Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients : a slow-titration regimen. Int J Clin Pract. 2006 ; 60(5) : 533-540. https://doi.org/10.1111/j.1368-5031.2006.00892.x
  17. Kurz AF, Erkinjuntti T, Small GW, Lilienfeld S, Damaraju CR. Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease. Eur J Neurol. 2003 ; 10(6) : 633-640. https://doi.org/10.1046/j.1468-1331.2003.00677.x
  18. Small G, Erkinjuntti T, Kurz A, Lilienfeld S. Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease. CNS Drugs. 2003 ; 17(12) : 905-914. https://doi.org/10.2165/00023210-200317120-00004
  19. Erkinjuntti T, Kurz A, Small GW, Bullock R, Lilienfeld S, Damaraju CV ; GAL-INT-6 Study Group. An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia. Clin Ther. 2003 ; 25(6) : 1765-1782. https://doi.org/10.1016/S0149-2918(03)80168-6
  20. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease : a randomised trial. Lancet. 2002 ; 359(9314) : 1283-1290. https://doi.org/10.1016/S0140-6736(02)08267-3
  21. Itoh T, Shimada Y, Terasawa K. Efficacy of Choto-san on vascular dementia and the protective effect of the hooks and stems of Uncaria sinensis on glutamateinduced neuronal death. Mech Ageing Dev. 1999 ; 111(2-3) : 155-173. https://doi.org/10.1016/S0047-6374(99)00062-7
  22. Liu X, Du J, Cai J, Liu X, Xu G, Lin A, Teng Q. Clinical systematic observation of Kangxin capsule curing vascular dementia of senile kidney deficiency and blood stagnation type. J Ethnopharmacol. 2007 ; 112(2) : 350-355. https://doi.org/10.1016/j.jep.2007.03.019
  23. Xu WJ, Li ZH, Shi YM, Zou YH. Clinical research of effect of Yishen Yangnao capsule on vascular dementia. Zhongguo Zhong Yao Za Zhi. 2007 ; 32(8) : 732-735.
  24. Zhu AH, Tian JZ, Zhong J, Yang CZ, Shi J, Yin JX. A clinical study on a randomized, double blind control of Chinese medicine granules in treatment of vascular dementia. China Zhongguo Zhong Yao Za Zhi. 2006 ; 31(20) : 1722-1725.
  25. Du GY, Zhu XC, Zhao JJ, Wang J, Tian JZ, Liu XF, Zhi HP, Zhao Y, Cao CY, Cui HF, Wang XR, Zhang CY. Clinical Study of Effect of Tianzhi Granule on Senile Vascular Dementia. Zhongguo Zhong Yao Za Zhi. 2003 ; 28(1) : 73-77.
  26. Tian JZ, Yin JX, Liu H, Yang CZ, Wang YY. Jian Nao Ning for treatment memory impairment in patients with mild or moderate multi-infarct dementia. J Tradit Chin Med. 2002 ; 22(4) : 247-251
  27. Liu T, Wang CH, Yang J. Modified sanjiasan decoction in regulating intelligence state of patients with vascular dementia. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 ; 25(6) : 492-495.
  28. Liu Y, Wei H, Shan B, Liu Q. Clinical observation on effect of dishengzhu decoction in treating vascular dementia. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004 ; 24(9) : 837-838.
  29. Fan XZ, Yang BL. Clinical study of shuizhitong capsule in treating senile vascular dementia. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004 ; 24(8) : 694-697.
  30. Huang JS, Lin QC, Huang RZ. Clinical study on effect of yuantong capsule in treating vascular dementia. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003 ; 23(11) : 815-818.
  31. Xia X, Shen XH, Liu YJ. Clinical observation on effect of baisuifang oral liquid in treating vascular dementia. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001 ; 21(8) : 569-572.
  32. Yan XP, Wang H, Zhang TZ. Clinical observation of effect on tongmai yizhi capsule in treating vascular dementia. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001 ; 21(8) : 573-575.
  33. Zhang BL, Wang YY, Chen RX. Clinical randomized double-blinded study on treatment of vascular dementia by jiannao yizhi granule. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 ; 22(8) : 577-580.
  34. Zhao Y, Zhou W, Gao P. Clinical study on effect of xianlong capsule on senile vascular dementia. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1999 ; 19(10) : 585-588.
  35. Cheng W, Zhou W, Chen K. Clinical study on effect of huancongdan capsule in treating senile vascular dementia. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1998 ; 18(2) : 81-84.
  36. 黃堅紅. 中西医結合治療血管性痴呆22例. 中國臨床康復. 2002 ; 6(13) : 1932-1933.
  37. 林巍巍. 中西医結合治療血管性痴呆31例臨床觀察. 河南中医. 2004 ; 24(11) : 59-60.
  38. 馬瑞莲, 王静, 許東, 馬風琴. 中西医結合治療血管性痴呆病臨床研究. 宁夏医學雜志. 2007 ; 29(4) : 321-322.
  39. 潘少骅, 劉鳳英, 彭小南. 中西医結合治療血管性痴呆症36例觀察. 實用中医藥雜志. 2005 ; 21(12) : 732-733.
  40. 歐陽眞理. 中西医結合治療血管性痴呆療效觀察. 深圳中西医結合雜志. 2005 ; 15(4) : 235.
  41. 吴婷婷, 王慶月. 中西医結合治療老年血管性痴呆40例临床觀察. 實用心腦肺血管病雜志. 2004 ; 12(5) : 292-293.
  42. 杜秦川, 馬瑞莲, 王静. 中西医結合治療老年血管性痴呆45例療效觀察. 山西中医 1997 ; 13(6) : 23-24.
  43. 申羅英, 劉英斌. 中西医結合治療血管性痴呆.浙江中西医結合雜志. 2009 ; 19(2) : 93-94.
  44. 王鳳香. 中西医結合治療血管性痴呆32例臨床觀察. 河北中医. 2008 ; 30(12) : 1291- 1292.
  45. 張連城, 張玉莲, 郭家奎, 王立存, 張静. 中西医結合治療血管性痴呆35例臨床觀察. 河北中医. 2007 ; 29(11) : 1000-1002.
  46. 郭會軍. 中西医結合治療血管性痴呆48例. 中医研究. 2005 ; 18(6) : 38-39.
  47. 錢仁義. 中西医結合治療血管性痴呆60例. 山西中医. 1999 ; 15(4) : 25-26.
  48. 錢仁義, 杜玉玲. 中西医結合治療血管性痴呆60例临床觀察. 江蘇中医. 2000 ; 21(2) : 16.
  49. 馬瑞莲, 王静, 許東, 馬風琴. 中西医結合治療血管性痴呆病臨床研究. 宁夏医學雜志. 2007 ;29(4) : 321-322
  50. 于文亞. 中西医結合治療血管性痴呆的結效觀察. 河北中医. 2008 ; 30(4) : 396-397.
  51. 邊曉東. 中西医結合治療血管性痴呆結效觀察. 實用中医藥雜志. 2008 ; 24(5) : 294.
  52. 周强, 蔡軍, 庄玉蘭. 中西医結合治療血管性痴呆臨床觀察. 中医藥學刊. 2006 ; 24(12) :2347-2348.
  53. 侯永翠, 黄旺惠. 中西医結合治療老年血管性痴呆臨床觀察. 實用中医藥雜志. 2006 ; 22(7) : 432-433.
  54. 吴效普. 中西医結合治療經中度血管性痴呆的臨床研究. 中國民族民間医藥. 2009 ; 4 : 19-20.
  55. 劉向敏, 東冉, 劉柏. 老年血管性痴呆中西医結合治療研究. 現代中西医結合雜志. 2002 ;11(23) : 2317-2318.
  56. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia : a quantative integration of the literature. Acta Psychiatr Scand. 1987 ; 76 : 465-479. https://doi.org/10.1111/j.1600-0447.1987.tb02906.x
  57. 강임옥, 박종연, 이용갑, 서수라, 김경하, 최숙자. 치매환자의 사회경제적 비용 분석. 서울. 건강보험연구원. 2005.
  58. 이재홍. 혈관성 치매의 임상 특성과 유형. 대한뇌졸중학회지. 2000 ; 2(2) : 121-125.
  59. Roman GC. Vascular dementia revisited : Diagnosis, pathogenesis, treatment and prevention. Med Clin North Am. 2002 ; 86 : 477-499. https://doi.org/10.1016/S0025-7125(02)00008-1
  60. Gustavo C, Romάn MD. Vascular dementia : Distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc. 2003 ; 51(5) : S296-S304.
  61. Thomas VS, Hageman PA. A preliminary study on the reliability of physical performance measures in older daycare canter clients with dementia. Int Psychogeriatr. 2002 ; 14(1) : 17-23. https://doi.org/10.1017/S1041610202008244
  62. Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord. 1999 ; 13(S3) : 155-123.
  63. Sugimoto H, Iimura Y, Yamanishi Y, Uamatsu K. Synthesis and structureactivity relationships of acetylcholinerase inhibitors : 1-benzyl-4-[(5,6-dimethoxy-1- oxoindan- 2 - yl ) -methyl ] piperidine hydrochloride and related compounds. J Med Chem. 1995 ; 38 : 4821-4829. https://doi.org/10.1021/jm00024a009
  64. Kumar V, Anand R, Messina J, Hartman R, Veach J. An efficacy and safety analysis of Exelon in Alzheimer's disease with concurrent vascular risk factors. Eur J Neurol. 2000 ; 7 : 159-169. https://doi.org/10.1046/j.1468-1331.2000.00046.x
  65. Moretti R, Torre P, Antonello RM, Cazzato G. Rivastigmine in subcortical vascular dementia : A comparison trial on efficacy and tolerability for 12 months follow-up. Eur J Neurol. 2001 ; 8 : 361-362. https://doi.org/10.1046/j.1468-1331.2001.00224.x
  66. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease : a randomised trial. Lancet 2002 ; 359 : 1283-1290. https://doi.org/10.1016/S0140-6736(02)08267-3
  67. Barnes CA, Danysz W, Parsons CG. Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal longterm potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats. Eur J Neurosci. 1996 ; 8 : 565-571. https://doi.org/10.1111/j.1460-9568.1996.tb01241.x
  68. Zajaczkowski W, Quack G, Danysz W. Infusion of (+)-MK-801 and memantine : Contrasting effects on radial maze learning in rats with entorhinal cortex lesion. Eur J Pharmacol, 1996 ; 296 : 239-246. https://doi.org/10.1016/0014-2999(95)00716-4
  69. Roman RC. Perspective in the treatment of vascular dementia. Drugs Today. 2000 ; 36 : 641-653.
  70. 전국한의과대학 신경정신과 교과서 편찬위원회 편. 증보판 한의신경정신과학. 파주 : 집문당. 2010 : 333.
  71. 김은선, 박치상, 박창국. 痴呆에 對한 文獻的 考察. 경산대학교 제한동의학술원 논문집. 1998 ; 3 : 366-367.
  72. 고병일, 고정수, 변기원, 손인철. 痴呆의 原因 및 治法에 대한 硏究. 한국전통의학지. 2000 ; 10(2) : 147.